|
|
Volumn 15, Issue 4, 2000, Pages 453-454
|
|
Should the results of the HOPE study affect nephrological practice?
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALPHA TOCOPHEROL;
ANTILIPEMIC AGENT;
ANTITHROMBOCYTIC AGENT;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
BRADYKININ;
RAMIPRIL;
AGED;
CARDIOVASCULAR DISEASE;
CLINICAL TRIAL;
COUGHING;
DIABETES MELLITUS;
DOSE TIME EFFECT RELATION;
DRUG EFFICACY;
EDITORIAL;
HEART INFARCTION;
HIGH RISK PATIENT;
HUMAN;
HYPERTENSION;
ISCHEMIC HEART DISEASE;
MEDICAL PRACTICE;
MICROALBUMINURIA;
MORTALITY;
NEPHROLOGY;
PRIORITY JOURNAL;
RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;
SCHOOL CHILD;
STROKE;
VASCULAR DISEASE;
|
|
EID: 0034106707
PISSN: 09310509
EISSN: None
Source Type: Journal
DOI: 10.1093/ndt/15.4.453 Document Type: Editorial |
|
Times cited : (6)
|
|
References (13)
|
